Printer Friendly

VACCINATION STATUS OF THE CHILDREN WITH NEUROLOGICAL DISORDERS AND ASSOCIATED FACTORS.

OP-17

Introduction: The aim of this study to evaluate vaccination status of the children with neurological disorders and associated factors.

Material and method: The patients and their parents who have been followed at Erciyes University Pediatric Neurology department and who accepted to join this study were included during the January 2013 to January 2015. A questionnaire form consisting of age, diagnosis age and gender of the children, mother's age and education status, vaccination status of the children, reasons of missing vaccination, history of administering to emergency department because of adverse events following immunization (AEFI) and history of vaccination with seasonal infuenza vaccine were administered.

Results: Three hundred and twenty-one patients whose mean age is 3,5[+ or -]4 years and 57% is male were included to the study. Mean age of the mothers was 32[+ or -]7 years and 50% of the mothers were graduated from primary school. Eighty percent of the patients had been diagnosed with epilepsy. It was determined that 17% of the patients had been missing immunized due to neurological disorders and 11% of them have been still missing immunized. Median age and diagnosis age, mean mother's age of the missing immunized patients with neurological disorders were smaller than the full-immunized (p=0,02; p=0,02; p=0,003 respectively). Application rate to the emergency department due to AEFI was higher in the missing immunized patients than the full-vaccinated (p<0,001). The most common reason for the missing vaccination of the patients with neurological disorders was frequent or long-lasting hospitalization (55%). It was determined that 12% of the pediatric neurology patients have been immunized with infuenza vaccine.

Conclusion: Neurological problem is one of the reasons for the missing immunization. Therefore, it is important to evaluate the vaccination status and the missing opportunities of the patients, prevent unreal contraindications and inform the parents in every visit in both first step and treatment centers. It is especially important to follow the patients who were frequent or long-lasting hospitalized, small aged, and who experienced AEFI. However, using of the infuenza vaccine should be generalized for the pediatric neurology patients.

Meda Kondolot (1), Ayse Kacar Bayram (2), Mehmet Canpolat (2), Faruk Karakas (3), Ferhan Elmali (4), Hakan Gumus (2), Sefer Kumandas (2), Huseyin Per (2)

(1) Department of Pediatrics, Division of Social Pediatrics, Erciyes University School of Medicine, Kayseri, Turkey

(2) Department of Pediatrics, Division of Child Neurology, Erciyes University School of Medicine, Kayseri, Turkey

(3) Sixth-class Medical Student, Erciyes University School of Medicine, Kayseri, Turkey

(4) Department of Biostatistics and Bioinformatics, Erciyes University School of Medicine, Kayseri, Turkey

COPYRIGHT 2017 AVES
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2017 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Oral Posters
Author:Kondolot, Meda; Bayram, Ayse Kacar; Canpolat, Mehmet; Karakas, Faruk; Elmali, Ferhan; Gumus, Hakan;
Publication:Erciyes Medical Journal
Article Type:Report
Date:Mar 1, 2017
Words:430
Previous Article:NONINVASIVE HEMOGLOBIN MEASUREMENT: IS IT CONVENIENT FOR PICU.
Next Article:ASSESSMENT OF MICRONUTRIENT LEVELS AND THEIR RELATIONSHIP WITH COMPONENTS OF METABOLIC SYNDROME IN CHILDREN AND ADOLESCENTS AND WITH OBESITY AND...
Topics:

Terms of use | Privacy policy | Copyright © 2022 Farlex, Inc. | Feedback | For webmasters |